CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Travere Therapeutics Insider Sold Shares Worth $13,135,397, According to a Recent SEC Filing

Neutral
AI Analysis

Summary

An insider at Travere Therapeutics sold shares worth $13,135,397 according to an SEC filing. This is a routine disclosure with no material impact indicated.

Importance:2/10
Sentiment:
0.00
insider_tradingsec_filingstock_sale
Related Companies

Read the original article

Published by yahoo_finance on September 18, 2026 7:42 AM

Read Original